SRZNSurrozen, Inc. Common

CSNasdaq (XNAS)·USD

Identity

Security key: 22068
Ticker: SRZN
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-08-12
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: SRZN

Detail

Enriched 2026-08-14 20:47

Market cap: $284,318,568.02
Shares outstanding (class): 11,610,371
Shares outstanding (weighted): 11,753,558
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 44
Location: SOUTH SAN FRANCISCO, CA
Homepage: https://www.surrozen.com
Description: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Market cap and share counts drift.

Funds holding this security

8 funds · 8 positions · $5.35M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$2.84M	0.00%	97,635 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$1.87M	0.00%	64,211 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$356.2K	0.03%	12,228 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$109.3K	0.00%	3,751 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$101.8K	0.00%	3,495 NS	FIGI
TIFF MULTI-ASSET FUND TIFF Investment Program	—	$35.9K	0.00%	1,231 NS	FIGI
1290 VT Micro Cap Portfolio EQ Advisors Trust	—	$26.3K	0.02%	902 NS	FIGI
Total Stock Market Index Trust John Hancock Variable Insurance Trust	—	$5.1K	0.00%	175 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERSRZN
FIGI_COMPOSITEBBG00XY94S95
FIGI_SHARE_CLASSBBG00XY94SB2
CIK0001824893
ISINUS86889P2083
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Surrozen is a biopharmaceutical company developing biological products, fitting the healthcare biotechnology classification.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.